ERBB2 and neoplasm: Interestingly, in human breast cancer cell lines, miR-125a act as a tumor suppressor and is underexpressed, interfering with the expression of ERBB2, ERBB3 and HUR (an RNA binding protein), promoting antiproliferative effects [94, 95].